Basecamp Research

Basecamp Research, founded in 2019, is an AI company focusing on tackling challenges in the life sciences through innovative methods. Their slogan, "Beyond Known Biology," reflects their dedication to exploring uncharted territories within biology. The company's focus lies in discovering and designing proteins through artificial intelligence, utilizing a proprietary knowledge graph of nature. This approach allows them to create tailored proteins for various applications in pharma, food, and industrial sectors, eliminating the need for expensive and time-consuming directed evolution campaigns. Basecamp Research operates at the intersection of AI, biotechnology, pharmaceuticals, sustainability, clean energy, and machine learning. Headquartered in the United Kingdom, the company secured a noteworthy $60.00M Series B investment on 09 October 2024. The investors in this round included True Ventures, Redalpine, Hummingbird Ventures, Singular, S32, André Hoffmann, Vice-Chairman of Roche, Feike Sijbesma, Chair of Royal Philips and former CEO of DSM, and Paul Polman. The company's ambitious team, comprising explorers, scientists, and policy experts, strives to draw insights from nature's diversity while delivering life-changing breakthroughs to those in need. Basecamp Research's pioneering approach and recent investment signify a noteworthy trajectory in the AI and life sciences sectors.